Fertility Tourism Market Size & Growth Forecast 2026–2035, By Segments (Age Group, Treatment, Country), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Fertility Tourism Market size was assessed at USD 1.87 Billion in 2025 and is poised to grow at a 24.4% CAGR between 2026 and 2035, surpassing USD 16.6 Billion by 2035. The industry revenue for 2026 is estimated at USD 2.28 billion.
Get more details on this report
Request Free Sample ReportFertility Tourism Market Intelligence Snapshot
Regional Market Dynamics
- Europe leads due to a strong network of fertility clinics, advanced reproductive treatments, and established cross-border patient flows seeking diverse procedures and reduced waiting times across the region.
- Asia Pacific is growing at 26.84% CAGR driven by affordable treatment options, expanding fertility centers, improved clinical capabilities, and increasing international patient flows through structured medical travel services.
Segment Momentum
- The 35–44 age group accounted for 44.57% of the market in 2025 because patients increasingly travel abroad for timely access to specialized, cost-effective fertility treatments while remaining broadly eligible for assisted reproduction.
- Donor Egg Treatment is the fastest-growing segment as patients seek international access to donor programs when domestic availability, regulations, or treatment costs limit conventional fertility options.
Market Expansion Drivers
- Rising infertility prevalence increasing cross-border demand for IVF and reproductive treatment services.
- Expansion of advanced IVF clinics and ART infrastructure improving international patient accessibility.
- Growing fertility financing and treatment affordability programs supporting medical travel adoption.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Leading companies in the fertility tourism market include Bumrungrad International Hospital (Thailand), Apollo Fertility (India), Barcelona IVF (Spain), IVF-Life Group (Spain), Alpha IVF & Women’s Specialists (Malaysia), Manchester Fertility Services Ltd. (United Kingdom), San Diego Fertility Center (United States), Eva Fertility Clinics (Cyprus), Genesis IVF Centre (India).Regional and Segment Outlook
EuropeMarket Growth Drivers and Industry Trends
As infertility affects a larger share of the reproductive-age population, more patients move beyond local treatment pathways and actively compare international options for IVF, egg donation, ICSI, surrogacy support, and related reproductive services. This transitions patient behavior from episodic domestic care to planned medical travel, particularly when home-country systems involve long waiting periods, restrictive eligibility criteria, limited donor availability, or high out-of-pocket costs. In practice, the fertility tourism market benefits because rising clinical need translates into a larger pool of patients willing to travel for faster treatment initiation and access to procedures not readily available at home, increasing demand for the market through a combination of urgency, treatment customization, and broader choice of reproductive specialists.
Expansion of advanced IVF clinics and ART infrastructure improving international patient accessibility
The build-out of modern IVF clinics, embryology labs, cryopreservation capabilities, and coordinated international patient services makes cross-border treatment logistically easier and clinically more credible, which directly influences market adoption. As providers invest in multilingual staff, digital consultation pathways, airport-to-clinic coordination, transparent treatment packages, and integrated diagnostics, overseas patients face fewer frictions in selecting and completing care abroad. For the fertility tourism market, this infrastructure expansion does not just add capacity; it strengthens patient confidence in treatment quality and continuity, allowing destination countries and specialist clinic networks to capture a larger share of globally mobile reproductive care demand.
Growing fertility financing and treatment affordability programs supporting medical travel adoption
High upfront costs remain one of the most decisive barriers in reproductive care, so the spread of installment plans, bundled IVF packages, employer-linked fertility benefits, and specialized medical financing changes the addressable patient base in a practical way. When patients can spread payments over time or compare lower total treatment costs abroad against domestic pricing, cross-border care becomes a financially manageable decision rather than a deferred one. This is especially important in the fertility tourism market, where travel, accommodation, medication, and repeated cycles can quickly compound expenses; affordability programs reduce that friction and increase market penetration by enabling more patients to commit to treatment timelines that would otherwise be postponed or abandoned.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising infertility prevalence increasing cross-border demand for IVF and reproductive treatment services | 2.00% | Moderate | Europe, Asia Pacific | High | Near Term |
| Expansion of advanced IVF clinics and ART infrastructure improving international patient accessibility | 1.80% | High | Europe, Asia Pacific | High | Mid Term |
| Growing fertility financing and treatment affordability programs supporting medical travel adoption | 1.40% | Moderate | North America, Asia Pacific | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
Europe held the largest regional share of the fertility tourism market in 2025, backed by its well-established network of fertility clinics, broad availability of advanced reproductive procedures, and cross-border patient flows within and into the region. The market’s leadership is aided by the concentration of experienced specialists and treatment centers that attract patients seeking a wider range of services, shorter waiting times, or access to procedures that may be limited in their home countries. In practice, this creates a steady stream of international demand centered on destinations with recognized clinical capabilities and established medical travel infrastructure.
Asia Pacific is set to expand at a 26.84% CAGR over the forecast period, with the fertility tourism market gaining momentum as patients increasingly look to the region for comparatively affordable treatment options and improving clinical capabilities. Growth is being fueled by the expansion of private fertility centers, rising visibility of destination-based reproductive care, and a stronger ability among regional providers to serve international patients through packaged treatment pathways. As more patients weigh cost, access, and clinic availability together, adoption is accelerating across key medical travel destinations in the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Quality-Centered CareGermany's fertility tourism market is supported by well-established clinical standards and highly specialized reproductive healthcare providers. Germany continues to attract patients seeking reliable treatment quality, although regulatory requirements influence the range of fertility services available to international visitors.
France 🇫🇷
Regulated Clinical ExcellenceFrance supports fertility tourism through specialized reproductive medicine centers operating within a carefully regulated healthcare framework. France remains attractive for patients seeking clinically rigorous treatment, experienced fertility specialists, and comprehensive reproductive health services aligned with established medical standards.
Italy 🇮🇹
Personalized Fertility CareItaly offers fertility tourism through specialized clinics that emphasize individualized treatment plans and patient-centered reproductive care. Italy continues attracting international patients seeking experienced clinicians, advanced IVF procedures, and integrated healthcare services within established fertility centers.
Japan 🇯🇵
Specialized Reproductive ServicesJapan emphasizes technologically advanced fertility treatment supported by experienced specialists and modern clinical infrastructure. International interest in Japan is driven by high-quality reproductive care, particularly among patients seeking advanced laboratory procedures and personalized treatment protocols.
South Korea 🇰🇷
Integrated Medical TravelSouth Korea combines fertility treatment with its established medical tourism ecosystem, offering coordinated patient services and advanced reproductive technologies. South Korea continues strengthening multilingual support, digital patient engagement, and streamlined care pathways for international fertility travelers.
United States 🇺🇸
Advanced Treatment DestinationThe U.S. attracts fertility tourism through specialized reproductive medicine, advanced assisted reproductive technologies, and access to complex treatment options. International patients seek U.S. clinics for individualized care, donor programs, and sophisticated laboratory capabilities that support diverse fertility needs.
Segment Leadership and Growth Trends
Fertility Tourism Market Share (%), Age Group, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportWithin the fertility tourism market, the 35-44 age group held the dominant position in 2025 with a 44.57% share. This segment remains dominant because it sits at the point where fertility treatment demand becomes more immediate while patients still retain relatively broad treatment eligibility across common assisted reproduction pathways. Many individuals in this age band are also more willing to travel internationally for treatment in order to manage waiting times, improve access to specialized clinics, and secure more cost-efficient fertility care, which helps sustain its leadership in the fertility tourism market.
The 45-54 age group is emerging as the fastest-growing segment in the fertility tourism market as patients increasingly seek cross-border access to treatment options that may be less available, more restrictive, or more costly in their home countries. Growth in this segment is being underpinned by rising demand for age-appropriate fertility solutions and greater willingness among older patients to pursue international clinics that offer tailored protocols and broader treatment pathways. Compared with younger age groups, this segment’s momentum is more directly tied to the need for expanded access and treatment flexibility, which is accelerating its uptake in fertility tourism.
Treatment Segment Analysis: IVF With Own Egg (Largest Segment) vs Donor Egg Treatment (Fastest-Growing Segment)
In 2025, IVF With Own Egg accounted for a 53.49% share of the fertility tourism market, making it the largest treatment segment. its position is underpinned by the fact that it is often the first-line option for patients pursuing assisted reproduction abroad before moving to third-party reproductive approaches. Demand stays concentrated in this segment because many patients prefer treatment using their own gametes when clinically feasible, and international fertility clinics are well equipped to deliver these procedures at competitive prices and with established medical workflows, reinforcing its scale in the fertility tourism market.
Donor Egg Treatment is the fastest-growing treatment segment in the fertility tourism market due to increasing cross-border demand from patients who need alternatives to conventional IVF using their own eggs. Its momentum is closely linked to practical access factors, especially when patients face limited donor availability, regulatory constraints, or high treatment costs domestically. Relative to other treatment options, donor egg treatment is gaining traction because fertility tourism often provides a clearer route to timely care and expanded donor program access, making international treatment a more viable solution for this patient group.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Age Group | 18-24, 25-34, 35-44, 45-54 | 35-44 | 45-54 |
| Treatment | Donor Egg Treatment, IVF With Own Egg, Surrogacy, Donor Embryo, Sperm Donation | IVF With Own Egg | Donor Egg Treatment |
| Country | U.S., UK, Spain, Czech Republic, Portugal, Thailand, Malaysia, India, South Korea, Turkey | Turkey | Spain |
Competitive Landscape and Market Positioning
1. Bumrungrad International Hospital (Thailand)
2. Apollo Fertility (India)
3. Barcelona IVF (Spain)
4. IVF-Life Group (Spain)
5. Alpha IVF & Women’s Specialists (Malaysia)
6. Manchester Fertility Services Ltd. (United Kingdom)
7. San Diego Fertility Center (United States)
8. Eva Fertility Clinics (Cyprus)
9. Genesis IVF Centre (India)
The fertility tourism market is increasingly shaped by integrated healthcare and travel support services designed to improve patient convenience and treatment accessibility. Clinics are adopting teleconsultation platforms, multilingual support systems, and personalized treatment coordination to attract international patients. Competitive differentiation is also being influenced by specialized fertility programs, advanced reproductive technologies, and patient-centric care models.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Sabine Hospitals | Jun-24 | Sabine Hospitals secured USD 50 million in a funding round led by CX Partners. This capital infusion is earmarked for expanding clinical service offerings and upgrading operational infrastructure, enhancing the hospital’s capacity to support complex reproductive healthcare procedures and improve patient outcomes in the competitive fertility treatment sector. |
| Birla Fertility & IVF | Aug-23 | Birla Fertility & IVF, part of the CK Birla Group, announced a USD 59.4 million investment plan to scale its presence in the Indian market. The strategy focuses on establishing 10–12 new clinical centers across southern India within a two-year timeframe, significantly increasing its operational footprint and regional capacity for fertility services. |
| Alpha IVF Group | Jan-26 | Alpha IVF Group began construction of an international-standard fertility center in Bali. This facility is designed to provide high-end reproductive healthcare services tailored for medical tourists, marking a strategic geographic expansion that strengthens Bali’s status as a regional hub for fertility tourism and increases the availability of advanced IVF treatments. |
| TMRW Life Sciences | Mar-24 | TMRW Life Sciences introduced CryoLink, a specialized workstation for the digital management of frozen specimen inventories in fertility clinics. By integrating with TMRW’s automated storage solutions and Digital Specimen Management system, this technology enables enhanced laboratory standards and operational efficiency for high-volume fertility treatment providers globally. |
| First Fertility PGS Center Limited | Jun-25 | First Fertility PGS Center Limited launched a dedicated Indian Lounge in Thailand to facilitate cross-border patient intake. This initiative streamlines the patient experience for those traveling from India for reproductive procedures, reinforcing the company's competitive positioning in the international fertility tourism market through improved concierge and support services. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Fertility Tourism Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Fertility Tourism Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the fertility tourism market?
What is the projected value of the fertility tourism industry by 2035?
What factors are driving cross-border demand in the fertility tourism market?
How are clinic infrastructure and affordability programs supporting growth in the fertility tourism market?
Why does the 35–44 age group lead the fertility tourism market?
What is driving the growth of Donor Egg Treatment in the fertility tourism market?
Why does Europe lead the fertility tourism market?
What is driving fertility tourism growth in Asia Pacific?
Which companies are driving growth in the fertility tourism landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization